CZ298217B6 - Arylsubstituovaný piperazin, meziprodukt pro jehoprípravu a farmaceutický prostredek s jeho obsahem - Google Patents

Arylsubstituovaný piperazin, meziprodukt pro jehoprípravu a farmaceutický prostredek s jeho obsahem Download PDF

Info

Publication number
CZ298217B6
CZ298217B6 CZ0399799A CZ399799A CZ298217B6 CZ 298217 B6 CZ298217 B6 CZ 298217B6 CZ 0399799 A CZ0399799 A CZ 0399799A CZ 399799 A CZ399799 A CZ 399799A CZ 298217 B6 CZ298217 B6 CZ 298217B6
Authority
CZ
Czechia
Prior art keywords
alkyl
aryl
piperazine
substituted
pharmaceutically acceptable
Prior art date
Application number
CZ0399799A
Other languages
Czech (cs)
English (en)
Other versions
CZ399799A3 (cs
Inventor
Jolliffe@Linda
Murray@William
Pulito@Virginia
Reitz@Alan
Li@Xiaobing
Mulcahy@Linda
Maryanoff@Cynthia
Villani@Frank
Original Assignee
Ortho-Mcneil Pharmaceutical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho-Mcneil Pharmaceutical, Inc. filed Critical Ortho-Mcneil Pharmaceutical, Inc.
Publication of CZ399799A3 publication Critical patent/CZ399799A3/cs
Publication of CZ298217B6 publication Critical patent/CZ298217B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CZ0399799A 1997-05-12 1998-05-08 Arylsubstituovaný piperazin, meziprodukt pro jehoprípravu a farmaceutický prostredek s jeho obsahem CZ298217B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4623697P 1997-05-12 1997-05-12

Publications (2)

Publication Number Publication Date
CZ399799A3 CZ399799A3 (cs) 2000-04-12
CZ298217B6 true CZ298217B6 (cs) 2007-07-25

Family

ID=21942353

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ0399799A CZ298217B6 (cs) 1997-05-12 1998-05-08 Arylsubstituovaný piperazin, meziprodukt pro jehoprípravu a farmaceutický prostredek s jeho obsahem

Country Status (28)

Country Link
US (4) US6071915A (ru)
EP (1) EP0984777B1 (ru)
JP (1) JP4189867B2 (ru)
KR (1) KR100440755B1 (ru)
CN (3) CN1149081C (ru)
AP (1) AP1349A (ru)
AR (1) AR012686A1 (ru)
AT (1) ATE250033T1 (ru)
AU (1) AU7366998A (ru)
BR (1) BR9809804A (ru)
CA (1) CA2289987C (ru)
CZ (1) CZ298217B6 (ru)
DE (1) DE69818255T2 (ru)
DK (1) DK0984777T3 (ru)
EA (1) EA001904B1 (ru)
ES (1) ES2206928T3 (ru)
HK (1) HK1024630A1 (ru)
HU (1) HUP0100048A3 (ru)
IL (1) IL132836A0 (ru)
MY (2) MY122095A (ru)
NO (1) NO314144B1 (ru)
NZ (1) NZ500992A (ru)
PL (1) PL192596B1 (ru)
PT (1) PT984777E (ru)
TR (1) TR199902971T2 (ru)
TW (1) TW512146B (ru)
WO (1) WO1998051298A1 (ru)
ZA (1) ZA983968B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2768055A1 (fr) * 1997-09-11 1999-03-12 Synthelabo Utilisation de derives de sulfonanilide pour obtenir un medicament destine au traitement de l'ejaculation retrograde ou de l'aspermie
ZA991319B (en) 1998-02-20 2000-11-20 Ortho Mcneil Pharm Inc Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
EP1346983A3 (en) * 1998-02-20 2003-12-03 Ortho-Mcneil Pharmaceutical, Inc. Phthalimido arylpiperazines as alpha 1A receptor antagonists useful in the treatment of benign prostatic hyperplasia
TW536538B (en) 1998-02-20 2003-06-11 Ortho Mcneil Pharm Inc Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
US20020082421A1 (en) * 2000-09-14 2002-06-27 Abdel-Magid Ahmed F. Novel solid salt forms of N-[2-[4-[2-(1- methylethoxy)phenyl]-1-piperazinyl]-2-oxo-1piperidineacetamide
EE200300250A (et) 2000-11-30 2003-10-15 Ranbaxy Laboratories Limited 1,4-diasendatud piperasiini derivaadid, mis on kasulikud uroselektiivsete alfa1-adrenoretseptorite blokaatoritena
EP1758583A2 (en) * 2004-05-31 2007-03-07 Ranbaxy Laboratories Limited Arylpiperazine derivatives useful as adrenergic receptor antagonists
WO2006092710A1 (en) * 2005-03-02 2006-09-08 Ranbaxy Laboratories Limited Metabolites of 2-{3-[4-(2-isopropoxyphenyl) piperazin-1-yl]-propyl}-3a,4,7,7a-tetrahydro-1h-isoindole-1,3-(2h)-dione
WO2007029156A2 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Isoindoledione derivatives as adrenergic receptor antagonists
CN102391169B (zh) * 2011-10-17 2015-10-28 上海化学试剂研究所 N-(5-甲氧基-3-吲哚乙基)-4-取代苯基哌嗪-1-乙酰胺的制备方法
CN103387531A (zh) * 2012-05-10 2013-11-13 广州医学院 酰胺类芳基哌嗪衍生物及其制备方法和在抗良性前列腺增生中的应用
CN103980195A (zh) * 2014-04-28 2014-08-13 广州医科大学 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069336A (en) * 1976-02-25 1978-01-17 Chemisches Laboratorium Fritz-Walter Lange Gmbh & Co Kg (2-oxo-pyrrolidines)-acetic hydrazides
WO1984004302A1 (en) * 1983-04-27 1984-11-08 Byk Gulden Lomberg Chem Fab Substituted picolinic acids, processes for their preparation, their use and medicaments containing them
EP0711757A1 (en) * 1994-11-08 1996-05-15 F. Hoffmann-La Roche AG 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy -pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5955878A (ja) 1982-09-24 1984-03-31 Chugai Pharmaceut Co Ltd 新規なフエニルピペラジン誘導体
JPS62135464A (ja) * 1985-12-10 1987-06-18 Nippon Kayaku Co Ltd フエニルピペラジン誘導体
GB8703749D0 (en) 1987-02-18 1987-03-25 Sandoz Ltd Piperazinecarboxylic acid
US5254552A (en) * 1988-05-24 1993-10-19 American Home Products Corporation Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
EP0558245A1 (en) * 1992-02-25 1993-09-01 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY Heterobicyclic compounds as antagogists of alpha-1 adrenergic and SHT1A receptors
FR2692894B1 (fr) * 1992-06-24 1994-10-14 Irceba Aryl-1-(o-alcoxy-phényl-4-pipérazinyl-1)-2, 3- ou 4-alcanols, leur procédé de préparation et leur utilisation pour la préparation de médicaments.
US5403847A (en) * 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
US5807856A (en) * 1995-11-15 1998-09-15 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonist
EP0881235A1 (fr) * 1997-05-26 1998-12-02 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Nouveaux ylures de phosphore, leur préparation et leurs utilisations notamment en tant que bases fortes faiblement nucléophiles
TW536538B (en) * 1998-02-20 2003-06-11 Ortho Mcneil Pharm Inc Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
US6063785A (en) * 1999-02-17 2000-05-16 Ortho-Mcneil Pharmaceutical Inc. Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
ZA991315B (en) * 1998-02-20 2000-11-20 Ortho Mcneil Pharm Inc Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069336A (en) * 1976-02-25 1978-01-17 Chemisches Laboratorium Fritz-Walter Lange Gmbh & Co Kg (2-oxo-pyrrolidines)-acetic hydrazides
WO1984004302A1 (en) * 1983-04-27 1984-11-08 Byk Gulden Lomberg Chem Fab Substituted picolinic acids, processes for their preparation, their use and medicaments containing them
EP0711757A1 (en) * 1994-11-08 1996-05-15 F. Hoffmann-La Roche AG 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy -pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists

Also Published As

Publication number Publication date
CN1149081C (zh) 2004-05-12
AP9901684A0 (en) 1999-12-31
CN1515556A (zh) 2004-07-28
NO995518L (no) 2000-01-11
MY122095A (en) 2006-03-31
CA2289987C (en) 2006-03-14
CA2289987A1 (en) 1998-11-19
NZ500992A (en) 2003-02-28
KR100440755B1 (ko) 2004-07-21
US6890921B1 (en) 2005-05-10
DK0984777T3 (da) 2003-12-08
EP0984777B1 (en) 2003-09-17
HUP0100048A2 (hu) 2001-07-30
PT984777E (pt) 2004-01-30
US20030220493A1 (en) 2003-11-27
WO1998051298A1 (en) 1998-11-19
NO314144B1 (no) 2003-02-03
KR20010012505A (ko) 2001-02-15
CN1264300A (zh) 2000-08-23
BR9809804A (pt) 2000-06-27
NO995518D0 (no) 1999-11-11
TW512146B (en) 2002-12-01
EP0984777A1 (en) 2000-03-15
JP2002511065A (ja) 2002-04-09
HUP0100048A3 (en) 2002-12-28
ZA983968B (en) 1999-11-11
ATE250033T1 (de) 2003-10-15
JP4189867B2 (ja) 2008-12-03
PL192596B1 (pl) 2006-11-30
IL132836A0 (en) 2001-03-19
AR012686A1 (es) 2000-11-08
DE69818255D1 (de) 2003-10-23
HK1024630A1 (en) 2000-10-20
CZ399799A3 (cs) 2000-04-12
US6593474B1 (en) 2003-07-15
EA001904B1 (ru) 2001-10-22
DE69818255T2 (de) 2004-12-23
US6071915A (en) 2000-06-06
CN1515563A (zh) 2004-07-28
MY127385A (en) 2006-11-30
TR199902971T2 (xx) 2001-03-21
AP1349A (en) 2004-12-17
CN1269807C (zh) 2006-08-16
ES2206928T3 (es) 2004-05-16
PL342518A1 (en) 2001-06-18
EA199900928A1 (ru) 2000-08-28
EP0984777A4 (en) 2001-04-25
AU7366998A (en) 1998-12-08

Similar Documents

Publication Publication Date Title
CZ298217B6 (cs) Arylsubstituovaný piperazin, meziprodukt pro jehoprípravu a farmaceutický prostredek s jeho obsahem
ES2233769T3 (es) Piperazinas tiofeno sustituidas utiles en el tratamiento de hiperplasia benigna de prostata.
AU766398B2 (en) Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
US6780994B2 (en) Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
AU2002300904B2 (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
EP1273572B9 (en) Thiophene substituted piperazines useful in the treatment of benign prostatic hyperplasia
MXPA99010518A (en) Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
US6063785A (en) Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
US6362338B1 (en) Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
AU2003204320B2 (en) Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
JPH0770046A (ja) アロファン酸誘導体
MXPA00008219A (en) Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia
CZ20003045A3 (cs) Ftalimidoarylpiperaziny jako antagonisty alfa IA receptorů použitelné při léčení benigního zbytnění prostaty

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20100508